Quick Answer
ADMA BIOLOGICS, INC. reported Operating Income of $191.44 million for fiscal year 2025.
ADMA BIOLOGICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $191.44M | +37.7% |
| 2024 | $138.98M | +542.5% |
| 2023 | $21.63M | +155.0% |
| 2022 | -$39.37M | +32.6% |
| 2021 | -$58.37M | +10.1% |
| 2020 | -$64.91M | -56.7% |
| 2019 | -$41.42M | +31.3% |
| 2018 | -$60.29M | -53.4% |
| 2017 | -$39.31M | -126.8% |
| 2016 | -$17.33M | -11.7% |
| 2015 | -$15.51M | +3.2% |
| 2014 | -$16.02M | -6.5% |
| 2013 | -$15.04M | -90.2% |
| 2012 | -$7.91M | -71.1% |
| 2011 | -$4.62M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.01M | +28.7% | +19.2% |
| June 30, 2025 | $42.80M | +9.2% | +22.7% |
| March 31, 2025 | $34.88M | +59.9% | -12.0% |
| September 30, 2024 | $39.64M | +356.4% | +1.1% |
| June 30, 2024 | $39.20M | +8387.7% | +79.6% |
| March 31, 2024 | $21.82M | +2784.0% | +151.2% |
| September 30, 2023 | $8.69M | +193.2% | +1936.2% |
| June 30, 2023 | -$473.0K | +94.8% | +41.8% |
- ADMA BIOLOGICS, INC. showed an increase of +37.7% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, ADMA BIOLOGICS, INC.’s operating income has grown by 4241.1% (from -$4.62 million to $191.44 million).
- The most recent figure is from ADMA BIOLOGICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: